Actinium Pharmaceuticals, Inc. (ATNM) stock
ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3084% below fair value
$1.05−0.02 (-1.87%)
Close on Nov 20, 2026Market cap $33.01MP/E 2.9Yield –
Actinium Pharmaceuticals gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2021 it was $244.00K.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $244.00K | – |
| FY2011 | Dec 31, 2011 | $0 | – |
| FY2010 | Dec 31, 2010 | $0 | – |
See a number that looks wrong?